Skip to main content
Livermore
Livermore
中文EN

GSK plc

GLAXF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001131399

No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $70.1M in total; no superinvestor holds it.

Other share classesGSK

13F holders, Q3 2024

Institutional positions in GSK plc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
2
0 vs. Q2 2024
Shares held
3.45M
−75.5K (−2.1%) vs. Q2 2024
Total value
$70.3M
+$2.00M (+2.9%) vs. Q2 2024
New holders
1
1 more added
Sold out
1
0 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GLAXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 2 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 1 institutionQ4 2022: 1 institutionQ1 2023: 1 institutionQ2 2023: 2 institutionsQ3 2023: 2 institutionsQ4 2023: 2 institutionsQ1 2024: 2 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 2 institutionsQ4 2025: 1 institutionQ1 2026: 2 institutionsQ2 2026: 2 institutions
Value heldQ3 2024: $70.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $44.5MQ4 2022: $53.4MQ1 2023: $53.9MQ2 2023: $61.2MQ3 2023: $62.4MQ4 2023: $65.4MQ1 2024: $76.8MQ2 2024: $68.3MQ3 2024: $70.3MQ4 2024: $56.8MQ1 2025: $58.2MQ2 2025: $60.0MQ3 2025: $64.1MQ4 2025: $73.8MQ1 2026: $77.9MQ2 2026: $70.1M
Institutions holding GLAXF and their total value by quarter
QuarterHoldersValue
Q2 20262$70.1M
Q1 20262$77.9M
Q4 20251$73.8M
Q3 20252$64.1M
Q2 20251$60.0M
Q1 20251$58.2M
Q4 20242$56.8M
Q3 20242$70.3M
Q2 20242$68.3M
Q1 20242$76.8M
Q4 20232$65.4M
Q3 20232$62.4M
Q2 20232$61.2M
Q1 20231$53.9M
Q4 20221$53.4M
Q3 20221$44.5M
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding GSK plc; share changes are against Q2 2024.

Institutions holding GLAXF in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Aristotle Capital Management, LLC3,451,869$70.2M0.13%+84,760+2.5%Added
Eagle Bay Advisors LLC3,060$62.2K0.02%+3,060New
Kennedy Capital Management, Inc.0$00.00%−163,308−100.0%Sold out